Name | Description | Industry | Official Website | Location | ||
---|---|---|---|---|---|---|
ViaCyte is a biotechnology company using stem cells to create pancreatic beta cell precursors for treating diabetes. | ||||||
SQZ Biotech is a biotechnology company using their cell engineering platform for developing cell therapies for treating immune disorders. | ||||||
Sonoma Biotherapeutics is developing engineered regulatory T cell (Treg) therapies to treat serious autoimmune and inflammatory diseases driven by an imbalanced immune system. | ||||||
Veralox Therapeutics is a small molecule drug discovery and development firm based in the Frederick Innovative Technology Center, Inc. | ||||||
Pandion Therapeutics is a Cambridge, Massachusetts-based company developing modular proteins, antibodies and bispecifics for autoimmune and inflammatory diseases. | ||||||
Semma Therapeutics is a biotechnology company making regenerative medicine therapies using stem cells. | ||||||
Bigfoot Biomedical is an insulin delivery pump founded in 2014. | ||||||
Biolinq, Inc. is a Needle-Free Blood Glucose Monitoring founded by Joshua Windmiller. | ||||||
Inversago Pharma is a Canadian biotech company at clinical-stage, specializing in the development of new therapies focusing on CB1 blockade. | ||||||
Code Biotherapeutics is a DNA-based Gene Therapy Vector founded in 2020 by Brian J. McVeigh, Lori Getts and Robert Getts. | ||||||
Seraxis is a company developing cell therapies for diabetes. | ||||||
Enthera is an IGFBP3 Inhibitors - Monoclonal Antibody, Fusion Proteins founded in 2016. | ||||||
A biotechnology company developing therapies and personalized diagnostics for celiac disease | ||||||
Diabetes & Obesity Therapies | ||||||
Immunomolecular Therapeutics is a company founded in 2015. | ||||||
IM Therapeutics is a personalized immuno-therapeutic drugs for autoimmune diseases founded in 2015. | ||||||
Abata Therapeutics is a treg Cell Therapies founded in 2021 by Richard Ransohoff. |